Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge

References

• Epstein S. (2006). Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clin Ther, 28:151–173.
   PubMed Web of Science ®Google Scholar
• Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ et al. (1997). Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med, 337:1641–1647.
   PubMed Web of Science ®Google Scholar
• Mitlak BH, Cohen FJ. (1997). In search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulators. Horm Res, 48:155–163.
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM, Griffin BT. (2008). Biopharmaceutical challenges associated with drugs with low aqueous solubility–the potential impact of lipid-based formulations. Adv Drug Deliv Rev, 60:617–624.
   PubMed Web of Science ®Google Scholar
• Tang B, Cheng G, Gu JC, Xu CH. (2008). Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today, 13:606–612.
   PubMed Web of Science ®Google Scholar
• Lentz BR, Carpenter TJ, Alford DR. (1987). Spontaneous fusion of phosphatidylcholine vesicles in the fluid phase. Biochemistry, 18:3321–3326.
   Google Scholar
• Payne NI, Timmins P, Ambrose CV, Ward MD, Ridgway F. (1986). Proliposomes: a novel solution to an old problem. J Pharm Sci, 75:325–329.
   PubMed Web of Science ®Google Scholar
• Betageri GV. (2005). Proliposomal drug delivery system. US Patent, 6,849,269.
   Google Scholar
• Song KH, Chung SJ, Shim CK. (2005). Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release, 106:298–308.
   PubMed Web of Science ®Google Scholar
• Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P. (2006). Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm, 319:162–168.
   PubMed Web of Science ®Google Scholar
• Deshmukh DD, Ravis WR, Betageri GV. (2008). Improved delivery of cromolyn from oral proliposomal beads. Int J Pharm, 358:128–136.
   PubMed Web of Science ®Google Scholar
• Gurrapu A, Jukanti R, Bobbala SR, Kanuganti S, Jeevana JB . (2011). Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol. DOI: 10.1016/j.apt.2011.06.005.
   Web of Science ®Google Scholar
• Jukanti R, Sheela S, Bandari S, Veerareddy PR. (2011). Enhanced bioavailability of exemestane via proliposomes based transdermal delivery. J Pharm Sci, 100:3208–3222.
   PubMed Web of Science ®Google Scholar
• Solanki AB, Parikh JR, Parikh RH. (2007). Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PharmSciTech, 8:E86.
   PubMed Web of Science ®Google Scholar
• Ruben GC, Wang JZ, Iqbal K, Grundke-Iqbal I. (2005). Paired helical filaments (PHFs) are a family of single filament structures with a common helical turn period: negatively stained PHF imaged by TEM and measured before and after sonication, deglycosylation, and dephosphorylation. Microsc Res Tech, 67:175–195.
   PubMed Web of Science ®Google Scholar
• Carr RL . (1965). Evaluation flow properties of solids. Chem Eng, 72:163–168.
   Google Scholar
• Malladi M, Jukanti R, Nair R, Wagh S, Padakanti HS, Mateti A. (2010). Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets. Acta Pharm, 60:267–280.
   PubMed Web of Science ®Google Scholar
• Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. (2010). To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B Biointerfaces, 76:170–178.
   PubMed Web of Science ®Google Scholar
• Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. (2004). Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 30:525–534.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegar S et al. (2007). Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharm Sci, 10:368–379.
   PubMed Web of Science ®Google Scholar
• Jha RK, Tiwari S, Mishra B. (2011). Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation. AAPS PharmSciTech, 12:650–657.
   PubMed Web of Science ®Google Scholar
• Arien A, Dupuy B. (1997). Encapsulation of calcitonin in liposomes depends on the vesicle preparation method. J Microencapsul, 14:753–760.
   PubMed Web of Science ®Google Scholar
• Al-Meshal AM. (1998). Oral administration of liposomes containing cyclosporine: a pharmacokinetic study. Int J Pharm, 168: 163–168.
   Web of Science ®Google Scholar
• Hiremath PS, Soppimath KS, Betageri GV. (2009). Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm, 380:96–104.
   PubMed Web of Science ®Google Scholar
• Xu H, He L, Nie S, Guan J, Zhang X, Yang X et al. (2009). Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release, 140:61–68.
   PubMed Web of Science ®Google Scholar
• Junping W, Maitani Y, Takayama K, Nagai T. (2000). In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome. Int J Pharm, 203:61–69.
   PubMed Web of Science ®Google Scholar
• Lin ZF, Zeng K, Zhou ZG, Li GF, Xie FM, Zhu XL et al. (2004). [Preparation and characterization of podophyllotoxin-dipalmitoylphosphatidylcholine proliposome]. Di Yi Jun Yi Da Xue Xue Bao, 24:784–6, 788.
   PubMedGoogle Scholar
• Wei NN, Lu BI. (2003). Preparation, morphology and Invitro release of chitosan coated liposomes of fluorouracil for colon targeting. Acta Pharm Sinica, 38: 53–56.
   Google Scholar
• Yang ZJ, Hino T, Kawashima Y. (1993). Studies on the size of rehydrated new liposome from scutellaria proliposome. J Chin Pharm Univ, 24: 161–164.
   Google Scholar
• Ye ZW, Hu QH, Liang WQ. (2002). [Preparation of interferon-alpha-containing liposomes by the powder bed grinding method]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 31:433–436.
   PubMedGoogle Scholar
• Chu MQ, Gu HC. (2002). The study on the preparation of tanshonones propoliposomes by the spray drying method. Chin Pharm J, 37: 32–35.
   Google Scholar
• Blazek-Welsh AI, Rhodes DG. (2001). SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm Res, 18:656–661.
   PubMed Web of Science ®Google Scholar
• Hulse WL, Forbes RT, Bonner MC, Getrost M. (2009). The characterization and comparison of spray-dried mannitol samples. Drug Dev Ind Pharm, 35:712–718.
   PubMed Web of Science ®Google Scholar
• Kulkarni SB, Betageri GV, Singh M. (1995). Factors affecting microencapsulation of drugs in liposomes. J Microencapsul, 12:229–246.
   PubMed Web of Science ®Google Scholar
• Blazek-Welsh AI, Rhodes DG. (2001). Maltodextrin-based proniosomes. AAPS PharmSci, 3:E1.
   PubMed Web of Science ®Google Scholar
• Ogiso T, Niinaka N, Iwaki M. (1996). Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci, 85:57–64.
   PubMed Web of Science ®Google Scholar
• Florence AT, Hillery AM, Hussain N, Jani PU. (1995). Nanoparticles as carriers for oral peptide absorption: studies on particles uptake and fate. J Control Release, 36: 39–46.
   Web of Science ®Google Scholar
• Staniforth J. Powder flow. In: Aulton M , ed. (2002). Pharmaceutics, The science of dosage form design, 2nd ed. Edinburgh: Churchill Livingstone, Longman group, 197–210.
   Google Scholar
• Plessis J, Ramachandran C, Weiner N, Miller DG . (1991). The influence of particle size of liposomes on deposition of drug into skin. Int J Pharm, 103: 277–282.
   Web of Science ®Google Scholar
• El-Shabouri MH. (2002). Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm, 249:101–108.
   PubMed Web of Science ®Google Scholar
• Porter CJH, Charman WN. (2001). Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev, 50: 21–44.
   PubMed Web of Science ®Google Scholar